What is Innovex International, Inc.'s earnings per share (EPS)?

Innovex International, Inc. (INVX) reported diluted earnings per share of $1.20 for fiscal year 2025. This represents a -56.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Innovex International, Inc. (INVX) Financials

INVX

Trailing 12 months to June 30, 2026

Revenue $997.5M +11.5% YoY

Net Income $61.6M -57.4% YoY

EPS (Diluted) $0.89 -57.8% YoY

Operating Cash Flow $157.5M +6.1% YoY

Market Cap $2.0B as of Oct 13, 2026

Price / Sales 2.0x on $997.5M revenue, trailing 12 months to June 30, 2026

Price / Earnings 32.6x on $61.6M net income, trailing 12 months to June 30, 2026

Price / Book 1.9x on $1.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INVX SEC filings page.

Innovex International, Inc. (INVX) reported $997.5M in revenue over the twelve months to Jun 30, 2026, up 11.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INVX FY2025 2026-10-04

Revenue surged to $978M, but the business works through scale absorption: product margins narrowed while cash generation strengthened.

FY2025 operating cash flow of $191M was more than twice net income, with $61M of depreciation and amortization providing a visible non-cash component. Net margin nevertheless fell to 8.5%, so the earnings decline did not represent a matching deterioration in cash production—an earnings-quality distinction the income statement alone obscures.

Gross margin compressed from 35.2% to 31.0%, so the stronger operating result did not come from a wider product-level spread. Revenue reached $978M while SG&A was $129M, indicating the business absorbed more scale without proportional overhead growth.

At FY2025, liabilities were $211M and debt-to-equity was 0.018x, showing a lightly levered funding structure. Current assets were 4.9x current liabilities, so short-term flexibility is coming from a substantial current-asset cushion rather than high borrowing.

Financial Health Signals

Financial Health Score 73/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Innovex International, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Innovex International, Inc. has an operating margin of 13.6%, meaning the company retains $14 of operating profit per $100 of revenue. This results in a moderate score of 35/100, indicating healthy but not exceptional operating efficiency. This is up from 7.4% the prior year.

Growth

Innovex International, Inc.'s revenue surged 48.0% year-over-year to $978.3M, reflecting rapid business expansion. This strong growth earns a score of 92/100.

Leverage

Innovex International, Inc. carries a low D/E ratio of 0.02, meaning only $0.02 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 4.91, Innovex International, Inc. holds $4.91 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 91/100.

Cash Flow

Returns

Innovex International, Inc.'s ROE of 7.9% shows moderate profitability relative to equity, earning a score of 60/100. This is down from 14.6% the prior year.

Altman Z-Score Safe

7.70

Innovex International, Inc. scores 7.70, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.0B) relative to total liabilities ($210.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Innovex International, Inc. passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.29x

For every $1 of reported earnings, Innovex International, Inc. generates $2.29 in operating cash flow ($190.9M OCF vs $83.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

51.37x

Innovex International, Inc. earns $51.37 in operating income for every $1 of interest expense ($132.6M vs $2.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$244.9M

YoY+9.2%

QoQ+2.5%

5Y CAGR+24.8%

10Y CAGR+5.6%

Innovex International, Inc. generated $244.9M in revenue in Q2 2026. This represents an increase of 9.2% from the same quarter a year earlier. Against the prior quarter it is up 2.5%.

EBITDA

$50.0M

YoY+32.7%

QoQ+991.2%

10Y CAGR-0.6%

Innovex International, Inc.'s EBITDA was $50.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 32.7% from the same quarter a year earlier. Against the prior quarter it is up 991.2%.

Net Income

$25.0M

YoY+63.1%

QoQ+250.1%

10Y CAGR-3.6%

Innovex International, Inc. reported $25.0M in net income in Q2 2026. This represents an increase of 63.1% from the same quarter a year earlier. Against the prior quarter it is up 250.1%.

EPS (Diluted)

$0.36

YoY+63.6%

QoQ+250.0%

10Y CAGR-9.3%

Innovex International, Inc. earned $0.36 per diluted share (EPS) in Q2 2026. This represents an increase of 63.6% from the same quarter a year earlier. Against the prior quarter it is up 250.0%.

Cash & Balance Sheet

Cash & Debt

$222.1M

YoY+222.8%

QoQ+10.6%

5Y CAGR-9.7%

10Y CAGR-7.6%

Innovex International, Inc. held $222.1M in cash against $19.0M in long-term debt as of Q2 2026.

Shares Outstanding

70M

YoY+1.7%

QoQ+1.7%

5Y CAGR+14.6%

10Y CAGR+6.4%

Innovex International, Inc. had 70M shares outstanding in Q2 2026. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 1.7%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

34.2%

YoY+2.2pp

QoQ-1.2pp

5Y change+10.3pp

10Y change-9.8pp

Innovex International, Inc.'s gross margin was 34.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.2 percentage points.

Operating Margin

13.8%

YoY+3.7pp

QoQ+22.9pp

5Y change+31.9pp

10Y change-18.0pp

Innovex International, Inc.'s operating margin was 13.8% in Q2 2026, reflecting core business profitability. This is up 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.9 percentage points.

Net Margin

10.2%

YoY+3.4pp

QoQ+17.2pp

5Y change+33.8pp

10Y change-15.1pp

Innovex International, Inc.'s net profit margin was 10.2% in Q2 2026, showing the share of revenue converted to profit. This is up 3.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 17.2 percentage points.

Return on Equity

2.4%

YoY+0.8pp

QoQ+4.0pp

5Y change+4.3pp

10Y change-0.3pp

Innovex International, Inc.'s ROE was 2.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.0 percentage points.

Capital Allocation

Share Buybacks

$1K

YoY-100.0%

QoQ-100.0%

Innovex International, Inc. spent $1K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

INVX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INVX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$997.5M	$978.3M+48.0%	$660.8M+18.9%	$555.5M+53.5%	$361.9M+12.2%	$322.4M-11.7%	$365.0M-12.0%	$414.8M+7.8%	$384.6M-15.6%	$455.5M-15.5%	$538.7M-36.2%	$844.3M-9.3%	$931.0M+6.7%	$872.4M+19.0%	$733.0M+21.9%	$601.3M
Cost of Revenue	$674.3M	$675.0M+57.6%	$428.2M+18.9%	$360.1M+16.5%	$309.1M-0.1%	$309.3M+14.7%	$269.7M-8.6%	$295.0M+0.5%	$293.6M-11.1%	$330.2M+0.6%	$328.4M-28.5%	$459.3M-10.6%	$513.5M-0.1%	$513.9M+13.8%	$451.7M+24.8%	$361.8M
Gross Profit	$323.2M	$303.3M+30.4%	$232.6M+19.0%	$195.4M+269.8%	$52.9M+300.9%	$13.2M-86.2%	$95.3M-20.5%	$119.8M+31.6%	$91.1M-27.3%	$125.2M-40.5%	$210.3M-45.4%	$385.0M-7.8%	$417.4M+16.4%	$358.5M+27.4%	$281.4M+17.5%	$239.5M
R&D Expenses	N/A	$6.7M+81.1%	$3.7M+23.3%	$3.0M+20.0%	$2.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$148.4M	$128.8M+10.9%	$116.2M+59.6%	$72.8M+23.0%	$59.2M-48.5%	$115.0M+21.0%	$95.1M-3.4%	$98.4M-3.6%	$102.1M-10.1%	$113.6M+113.3%	$53.2M-39.5%	$88.0M-5.1%	$92.8M-2.2%	$94.8M+15.3%	$82.2M+16.6%	$70.5M
Operating Income	$100.0M	$132.6M+170.2%	$49.1M-49.6%	$97.3M+28.3%	$75.8M+160.5%	-$125.3M-97.2%	-$63.6M-2367.5%	$2.8M+102.3%	-$122.7M-77.5%	-$69.1M-161.3%	$112.9M-54.6%	$248.8M-10.7%	$278.7M+24.7%	$223.5M+38.3%	$161.7M+24.7%	$129.6M
EBITDA	N/A	$193.4M+140.9%	$80.3M-33.1%	$119.9M+27.2%	$94.3M+199.3%	-$95.0M-204.6%	-$31.2M-184.6%	$36.8M+142.1%	-$87.4M-210.4%	-$28.2M-119.5%	$144.7M-48.2%	$279.3M-9.9%	$309.9M+22.5%	$252.9M+34.6%	$187.9M+23.1%	$152.7M
Interest Expense	$290K	$2.6M+6.3%	$2.4M-55.9%	$5.5M+36.5%	$4.0M+412.6%	$787K+26.7%	$621K+97.8%	$314K+7.9%	$291K+304.2%	$72K+157.1%	$28K+133.3%	$12K-65.7%	$35K0.0%	$35K+9.4%	$32K-39.6%	$53K
Income Tax	$37.2M	$45.2M+1718.7%	$2.5M-87.8%	$20.4M+111.8%	$9.7M+227.6%	$2.9M+109.4%	-$31.3M-459.2%	$8.7M+145.1%	-$19.3M-155.1%	$35.0M+54.5%	$22.6M-60.8%	$57.8M-18.3%	$70.7M+30.2%	$54.3M+26.5%	$42.9M+23.5%	$34.7M
Net Income	$61.6M	$83.3M-40.6%	$140.3M+89.8%	$73.9M+16.8%	$63.3M+149.2%	-$128.5M-317.6%	-$30.8M-1888.8%	$1.7M+101.8%	-$95.7M+4.9%	-$100.6M-208.0%	$93.2M-51.4%	$192.0M-8.0%	$208.7M+22.9%	$169.8M+42.5%	$119.2M+25.1%	$95.3M
EPS (Basic)	N/A	$1.21-57.1%	$2.82+18.0%	$2.39+15.5%	$2.07+157.0%	-$3.63-317.2%	-$0.87-1840.0%	$0.05+101.9%	-$2.58+4.1%	-$2.69-208.5%	$2.48-50.4%	$5.00-4.2%	$5.22+24.9%	$4.18+41.2%	$2.96+24.4%	$2.38
EPS (Diluted)	$0.89	$1.20-56.7%	$2.77	$2.29+13.9%	$2.01+155.4%	-$3.63-317.2%	-$0.87-1840.0%	$0.05+101.9%	-$2.58+4.1%	-$2.69-208.9%	$2.47-50.4%	$4.98-4.0%	$5.19+24.8%	$4.16+41.5%	$2.94+24.6%	$2.36
Diluted Shares (Avg)	N/A	69M+37.0%	51M	32M+2.8%	31M-11.0%	35M+0.2%	35M-2.5%	36M-2.5%	37M-1.0%	37M-0.6%	38M-2.2%	39M-4.1%	40M-1.7%	41M+0.8%	41M+0.5%	40M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$244.9M+9.2%	$239.0M-0.6%	$273.6M-1.7%	$240.0M+58.1%	$224.2M+86.3%	$240.4M+118.0%	$278.3M+8.0%	$151.8M+29.5%
Cost of Revenue	$161.2M+5.7%	$154.5M-5.7%	$194.5M+17.3%	$164.1M+65.5%	$152.5M+80.9%	$163.9M+107.7%	$165.8M+18.7%	$99.1M+11.2%
Gross Profit	$83.6M+16.6%	$84.5M+10.5%	$79.1M-29.7%	$75.9M+44.2%	$71.7M+99.0%	$76.5M+143.7%	$112.5M-4.7%	$52.7M+87.8%
SG&A Expenses	$39.1M+35.6%	$41.7M+29.1%	$32.0M-16.3%	$35.6M-6.3%	$28.8M+55.2%	$32.3M+51.6%	$38.3M+331.4%	$38.0M+97.6%
Operating Income	$33.8M+48.9%	-$21.8M-199.9%	$25.8M-4.1%	$62.3M+571.2%	$22.7M+73.6%	$21.9M-2.1%	$26.9M-59.5%	-$13.2M-155.1%
EBITDA	$50.0M+32.7%	-$5.6M-115.2%	$41.3M+5.9%	$77.6M+1529.4%	$37.7M+91.6%	$36.8M+35.8%	$39.0M-43.9%	-$5.4M-118.3%
Interest Expense	-$653K-218.5%	-$388K-155.4%	$654K+74.4%	$677K-7.1%	$551K-9.2%	$700K-2.6%	$375K-90.4%	$729K-51.9%
Income Tax	$10.4M+50.6%	-$4.9M-174.5%	$13.0M+397.1%	$18.7M+824.2%	$6.9M+59.3%	$6.6M+29.0%	-$4.4M-164.0%	-$2.6M-132.8%
Net Income	$25.0M+63.1%	-$16.7M-213.0%	$14.0M-56.1%	$39.2M-52.5%	$15.3M+61.0%	$14.8M-10.1%	$31.8M-39.8%	$82.6M+437.5%
EPS (Basic)	$0.36+63.6%	-$0.24-214.3%	$0.21+158.3%	$0.57-71.9%	$0.22-29.0%	$0.21-60.4%	-$0.36-160.0%	$2.03+306.0%
EPS (Diluted)	$0.36+63.6%	-$0.24-214.3%	$0.20+164.5%	$0.57	$0.22	$0.21	-$0.31	$1.99
Diluted Shares (Avg)	70M+0.5%	69M-0.8%	N/A	69M	69M	69M	N/A	42M

Not reported in any period shown, so not listed: R&D Expenses.

INVX Balance Sheet

INVX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.3B+5.9%	$1.2B+151.9%	$475.3M-51.0%	$970.0M-4.0%	$1.0B-12.3%	$1.2B-4.6%	$1.2B+1.2%	$1.2B-14.8%	$1.4B-4.2%	$1.5B+2.3%	$1.4B-1.4%	$1.4B+3.8%	$1.4B+11.8%	$1.2B+15.1%	$1.1B
Current Assets	$728.0M+13.5%	$641.4M+122.5%	$288.3M-61.6%	$750.0M+0.7%	$745.1M-13.7%	$863.2M-2.0%	$880.5M+3.2%	$853.0M-15.4%	$1.0B-4.6%	$1.1B-6.0%	$1.1B-0.3%	$1.1B+4.3%	$1.1B+16.9%	$924.4M+15.6%	$799.3M
Cash & Equivalents	$203.4M+177.6%	$73.3M-60.9%	$187.3M-27.8%	$259.4M-27.0%	$355.5M+2.7%	$346.0M-13.3%	$398.9M-4.6%	$418.1M-15.2%	$493.2M+16.5%	$423.5M+11.1%	$381.3M+27.7%	$298.7M-22.3%	$384.4M+49.4%	$257.2M-13.9%	$298.6M
Short-Term Investments	$0	$0-100.0%	$25.9M-19.6%	$32.2M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$248.4M-8.4%	$271.2M+92.1%	$141.2M-3.3%	$146.0M+0.2%	$145.7M-31.4%	$212.5M+3.6%	$205.1M+7.3%	$191.2M-34.3%	$291.1M-18.1%	$355.4M+3.2%	$344.5M-12.3%	$392.6M+6.6%	$368.4M+1.7%	$362.2M+30.4%	$277.8M
Accounts Receivable	$237.8M-0.7%	$239.5M+102.4%	$118.4M+30.3%	$90.9M-9.6%	$100.5M-13.5%	$116.2M+8.0%	$107.6M-9.3%	$118.7M-38.1%	$191.6M-10.2%	$213.5M-33.2%	$319.8M-14.5%	$374.0M+33.9%	$279.3M+6.1%	$263.2M+46.2%	$180.1M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$99.7M+65.7%	$60.2M+151.4%	$23.9M0.0%	$23.9M	N/A	N/A	$7.9M+3.0%	$7.7M-83.8%	$47.6M+38.6%	$34.4M	$0	N/A	N/A	N/A	N/A
Total Liabilities	$210.6M-12.0%	$239.3M+63.5%	$146.4M-79.6%	$718.7M-13.3%	$829.4M+656.4%	$109.6M-5.4%	$115.9M+20.3%	$96.3M-8.5%	$105.3M+0.3%	$105.0M+1.1%	$103.8M-49.1%	$204.1M+31.8%	$154.8M-6.2%	$165.0M+2.7%	$160.6M
Current Liabilities	$148.2M-8.9%	$162.7M+106.9%	$78.6M-10.2%	$87.6M-6.5%	$93.7M+9.5%	$85.5M-11.8%	$96.9M+18.9%	$81.5M-18.4%	$99.9M-1.5%	$101.5M+0.7%	$100.8M-49.2%	$198.6M+32.9%	$149.4M-3.6%	$155.1M+2.7%	$151.0M
Non-Current Liabilities	$62.4M-18.6%	$76.7M+13.2%	$67.8M-89.3%	$631.1M-14.2%	$735.7M+2948.7%	$24.1M+27.5%	$18.9M+27.8%	$14.8M+172.6%	$5.4M+55.2%	$3.5M+17.6%	$3.0M-45.0%	$5.4M+1.4%	$5.3M-46.2%	$9.9M+3.2%	$9.6M
Long-Term Debt	$18.9M-24.0%	$24.9M-38.6%	$40.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$57K
Total Equity	$1.1B+10.4%	$958.2M+191.3%	$328.9M+30.9%	$251.3M+39.2%	$180.6M-82.7%	$1.0B-4.5%	$1.1B-0.5%	$1.1B-15.3%	$1.3B-4.6%	$1.4B+2.4%	$1.3B+6.4%	$1.2B+0.3%	$1.2B+16.5%	$1.1B+15.3%	$925.2M
Retained Earnings	$285.3M+35.0%	$211.3M+44.8%	$145.9M-84.6%	$950.2M-2.4%	$973.1M-13.5%	$1.1B-4.7%	$1.2B-2.1%	$1.2B-13.9%	$1.4B-6.7%	$1.5B+5.3%	$1.4B+11.5%	$1.3B+19.5%	$1.1B+18.9%	$900.0M+15.3%	$780.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$1.3B+8.2%	$1.3B+7.7%	$1.3B+5.9%	$1.3B+10.7%	$1.2B+21.7%	$1.2B+17.1%	$1.2B+151.9%	$1.1B+12.4%
Current Assets	$788.5M+17.7%	$752.9M+19.0%	$728.0M+13.5%	$710.4M+4.9%	$670.1M-5.3%	$632.6M-11.5%	$641.4M+122.5%	$677.3M-4.5%
Cash & Equivalents	$222.1M+222.8%	$200.7M+194.7%	$203.4M+177.6%	$163.4M+63.5%	$68.8M-62.9%	$68.1M-65.6%	$73.3M-60.9%	$99.9M-44.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%
Inventory	$264.8M-4.9%	$253.0M-6.0%	$248.4M-8.4%	$275.2M-7.5%	$278.5M+36.0%	$269.3M+28.7%	$271.2M+92.1%	$297.5M+62.4%
Accounts Receivable	$240.1M+8.7%	$245.6M+4.1%	$237.8M-0.7%	$220.4M-2.1%	$221.0M+43.3%	$236.0M+72.1%	$239.5M+102.4%	$225.1M+68.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$106.0M+12.6%	$99.8M+32.0%	$99.7M+65.7%	$95.4M+298.6%	$94.1M+483.9%	$75.6M+363.9%	$60.2M+151.4%	$23.9M+47.4%
Total Liabilities	$269.2M+16.3%	$256.8M+18.0%	$210.6M-12.0%	$215.0M-5.9%	$231.5M-64.7%	$217.6M-67.8%	$239.3M+63.5%	$228.4M-67.3%
Current Liabilities	$157.5M+8.1%	$147.8M+1.3%	$148.2M-8.9%	$148.7M-14.9%	$145.7M+15.3%	$145.8M+9.2%	$162.7M+106.9%	$174.8M+63.8%
Non-Current Liabilities	$111.7M+30.3%	$109.0M+51.8%	$62.4M-18.6%	$66.2M+23.5%	$85.8M-83.8%	$71.8M-86.8%	$76.7M+13.2%	$53.6M-91.0%
Long-Term Debt	$19.0M-45.3%	$18.0M-8.3%	$18.9M-24.0%	$20.1M+62.7%	$34.8M	$19.7M	$24.9M-38.6%	$12.4M
Total Equity	$1.1B+6.3%	$1.0B+5.4%	$1.1B+10.4%	$1.0B+14.9%	$995.6M+182.4%	$978.4M+184.2%	$958.2M+191.3%	$904.4M+193.7%
Retained Earnings	$279.5M+20.4%	$254.5M+12.9%	$285.3M+35.0%	$271.3M+51.2%	$232.1M-75.0%	$225.4M-75.8%	$211.3M+44.8%	$179.5M-81.1%

INVX Cash Flow Statement

INVX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$157.5M	$190.9M+104.3%	$93.4M+23.2%	$75.9M+1405.5%	-$5.8M-115.1%	$38.4M+282.2%	-$21.1M-243.7%	$14.7M-67.7%	$45.5M-57.9%	$108.0M-56.2%	$246.5M+29.6%	$190.2M+27.4%	$149.3M-8.0%	$162.2M+2088.3%	-$8.2M-108.0%	$101.9M
Depreciation & Amortization	N/A	$60.7M+94.6%	$31.2M+37.7%	$22.7M+22.7%	$18.5M-39.2%	$30.4M-6.2%	$32.4M-4.8%	$34.0M-3.7%	$35.3M-13.8%	$41.0M+28.6%	$31.9M+4.5%	$30.5M-2.2%	$31.2M+6.2%	$29.3M+11.9%	$26.2M+14.0%	$23.0M
Stock-Based Compensation	N/A	$13.8M+4.2%	$13.2M+575.2%	$2.0M+116.3%	$907K-93.9%	$14.9M+15.3%	$12.9M-17.9%	$15.7M+16.8%	$13.5M-5.7%	$14.3M+16.8%	$12.2M-6.9%	$13.1M+10.7%	$11.9M+33.2%	$8.9M+54.8%	$5.7M+26.6%	$4.5M
Capital Expenditures	N/A	N/A	N/A	$32.6M+72.9%	$18.9M+88.8%	$10.0M-16.4%	$11.9M+3.8%	$11.5M-64.1%	$32.1M+16.1%	$27.6M+7.2%	$25.8M-4.9%	$27.1M-36.4%	$42.5M-0.2%	$42.6M-16.0%	$50.8M-9.7%	$56.2M
Free Cash Flow	N/A	N/A	N/A	$43.2M+275.2%	-$24.7M-186.8%	$28.4M+186.1%	-$33.0M-1139.7%	$3.2M-76.4%	$13.4M-83.3%	$80.4M-63.6%	$220.8M+35.4%	$163.1M+52.7%	$106.8M-10.7%	$119.6M+302.9%	-$58.9M-229.1%	$45.6M
Investing Cash Flow	$48.8M	-$18.7M-123.9%	$78.4M+341.9%	-$32.4M+13.6%	-$37.5M-1070.0%	-$3.2M+43.0%	-$5.6M+33.6%	-$8.5M+44.2%	-$15.2M+66.2%	-$44.9M+71.6%	-$157.8M-492.2%	-$26.7M+35.9%	-$41.6M+0.7%	-$41.9M+14.5%	-$49.0M+9.6%	-$54.2M
Financing Cash Flow	-$53.3M	-$44.9M+56.4%	-$103.1M-131.3%	-$44.6M-205.4%	$42.3M+274.0%	-$24.3M+3.5%	-$25.2M-2.5%	-$24.6M+75.2%	-$99.2M-17814.1%	$560K+102.6%	-$21.9M+70.2%	-$73.6M+60.6%	-$186.8M-5648.8%	$3.4M-72.5%	$12.3M+140.4%	$5.1M
Dividends Paid	N/A	$0-100.0%	$75.0M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$14.1M	$9.3M	$0	$0-100.0%	$20.8M-14.0%	$24.2M-3.2%	$25.0M-5.9%	$26.6M-73.4%	$100.0M	$0-100.0%	$24.2M-68.0%	$75.8M-60.2%	$190.2M+1802.0%	$10.0M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$37.0M-37.5%	$19.8M-36.2%	$52.2M+43.7%	$48.4M+122.7%	$59.2M+160.1%	$31.1M+146.6%	$36.3M+70.0%	$21.7M-77.4%
Depreciation & Amortization	$16.2M+8.3%	$16.2M+8.5%	$15.5M+28.4%	$15.4M+97.3%	$15.0M+127.3%	$14.9M+211.8%	$12.0M+97.9%	$7.8M+35.0%
Stock-Based Compensation	$3.4M-10.5%	$3.0M+68.0%	N/A	N/A	$3.8M	$1.8M+277.4%	N/A	N/A
Investing Cash Flow	-$13.2M+79.0%	-$5.6M+76.0%	-$10.0M+86.2%	$77.6M-49.5%	-$62.9M-5673.4%	-$23.5M-953.2%	-$72.0M-8674.9%	$153.7M+436.6%
Financing Cash Flow	-$2.4M-197.7%	-$16.9M-26.2%	-$2.8M-125.0%	-$31.2M+63.4%	$2.4M+113.1%	-$13.4M-30.6%	$11.1M+151.7%	-$85.3M-270.7%
Dividends Paid	N/A	N/A	$0	N/A	N/A	N/A	$0	N/A
Share Buybacks	-$1K-100.0%	$14.1M+2157.2%	$0	$0	$8.7M	$626K	$0	$0

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

INVX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INVX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	31.0%-4.2pp	35.2%0.0pp	35.2%+20.6pp	14.6%+10.5pp	4.1%-22.0pp	26.1%-2.8pp	28.9%+5.2pp	23.7%-3.8pp	27.5%-11.6pp	39.0%-6.6pp	45.6%+0.8pp	44.8%+3.8pp	41.1%+2.7pp	38.4%-1.5pp	39.8%
Operating Margin	13.6%+6.1pp	7.4%-10.1pp	17.5%-3.5pp	21.0%+59.8pp	-38.9%-21.5pp	-17.4%-18.1pp	0.7%+32.6pp	-31.9%-16.7pp	-15.2%-36.1pp	20.9%-8.5pp	29.5%-0.5pp	29.9%+4.3pp	25.6%+3.6pp	22.1%+0.5pp	21.6%
Net Margin	8.5%-12.7pp	21.2%+7.9pp	13.3%-4.2pp	17.5%+57.3pp	-39.9%-31.4pp	-8.4%-8.8pp	0.4%+25.3pp	-24.9%-2.8pp	-22.1%-39.4pp	17.3%-5.4pp	22.7%+0.3pp	22.4%+2.9pp	19.5%+3.2pp	16.3%+0.4pp	15.8%
Return on Equity	7.9%-6.8pp	14.6%-7.8pp	22.5%-2.7pp	25.2%+96.4pp	-71.2%-68.2pp	-2.9%-3.1pp	0.2%+8.9pp	-8.7%-1.0pp	-7.8%-14.6pp	6.9%-7.6pp	14.5%-2.3pp	16.8%+3.1pp	13.7%+2.5pp	11.2%+0.9pp	10.3%
Return on Assets	6.6%-5.2pp	11.7%-3.8pp	15.6%+9.0pp	6.5%+19.2pp	-12.7%-10.1pp	-2.7%-2.8pp	0.1%+8.2pp	-8.0%-0.8pp	-7.2%-13.6pp	6.4%-7.1pp	13.4%-1.0pp	14.4%+2.2pp	12.2%+2.6pp	9.5%+0.8pp	8.8%
Current Ratio	4.91+1.0x	3.94+0.3x	3.67-4.9x	8.57+0.6x	7.95-2.1x	10.09+1.0x	9.08-1.4x	10.46+0.4x	10.09-0.3x	10.41-0.7x	11.15+5.5x	5.67-1.6x	7.23+1.3x	5.96+0.7x	5.29
Debt-to-Equity	0.020.0x	0.03-0.1x	0.12-2.7x	2.86-1.7x	4.59+4.5x	0.110.0x	0.110.0x	0.090.0x	0.080.0x	0.080.0x	0.08-0.1x	0.160.0x	0.120.0x	0.15+0.2x	0.00
Asset Turnover	0.77+0.2x	0.55-0.6x	1.17+0.8x	0.37+0.1x	0.320.0x	0.320.0x	0.340.0x	0.320.0x	0.330.0x	0.37-0.2x	0.59-0.1x	0.640.0x	0.620.0x	0.590.0x	0.55
FCF Margin	N/A	N/A	7.8%+14.6pp	-6.8%-15.6pp	8.8%+17.9pp	-9.0%-9.8pp	0.8%-2.7pp	3.5%-14.2pp	17.6%-23.3pp	41.0%+21.7pp	19.3%+7.8pp	11.5%-2.2pp	13.7%+21.8pp	-8.0%-15.6pp	7.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	34.2%+2.2pp	35.4%+3.5pp	28.9%-11.5pp	31.6%-3.1pp	32.0%+2.0pp	31.8%+3.4pp	40.4%-5.4pp	34.7%+10.8pp
Operating Margin	13.8%+3.7pp	-9.1%-18.2pp	9.4%-0.2pp	25.9%+34.7pp	10.1%-0.7pp	9.1%-11.1pp	9.7%-16.1pp	-8.7%-29.2pp
Net Margin	10.2%+3.4pp	-7.0%-13.1pp	5.1%-6.3pp	16.4%-38.1pp	6.8%-1.1pp	6.1%-8.7pp	11.4%-9.0pp	54.4%+41.3pp
Return on Equity	2.4%+0.8pp	-1.6%-3.1pp	1.3%-2.0pp	3.8%-5.4pp	1.5%-1.2pp	1.5%-3.3pp	3.3%-12.7pp	9.1%+4.1pp
Return on Assets	1.9%+0.6pp	-1.3%-2.5pp	1.1%-1.6pp	3.1%-4.2pp	1.3%+0.3pp	1.2%-0.4pp	2.6%-8.5pp	7.3%+5.8pp
Current Ratio	5.01+0.4x	5.10+0.8x	4.91+1.0x	4.78+0.9x	4.60-1.0x	4.34-1.0x	3.94+0.3x	3.87-2.8x
Debt-to-Equity	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.03-1.8x	0.02-1.9x	0.03-0.1x	0.01-2.3x
Asset Turnover	0.180.0x	0.190.0x	0.220.0x	0.19+0.1x	0.18+0.1x	0.20+0.1x	0.23-0.3x	0.130.0x

Not reported in any period shown, so not listed: FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Innovex International, Inc. INVX	FY2025	$978.3M	$83.3M	8.5%	$2.0B	73/100
Enerflex Ltd. EFXT	FY2025	$2.6B	$64.0M	2.5%	$2.9B	43/100
Bristow Group Inc. VTOL	FY2025	$1.5B	$129.1M	8.7%	$1.2B	51/100
Select Water Solutions, Inc. WTTR	FY2025	$1.4B	$21.2M	1.5%	$2.5B	26/100
National Energy Services Reunited Corp. NESR	FY2025	$1.3B	$51.1M	3.9%	$2.1B	55/100
MRC GLOBAL INC. MRC	FY2024	$3.0B	$55.0M	1.8%	$1.2B	50/100

Where Innovex International, Inc. Ranks

Frequently Asked Questions

What is Innovex International, Inc.'s annual revenue?

Innovex International, Inc. (INVX) reported $978.3M in total revenue for fiscal year 2025. This represents a 48.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Innovex International, Inc.'s revenue growing?

Innovex International, Inc. (INVX) revenue grew by 48.0% year-over-year, from $660.8M to $978.3M in fiscal year 2025.

Is Innovex International, Inc. profitable?

Yes, Innovex International, Inc. (INVX) reported a net income of $83.3M in fiscal year 2025, with a net profit margin of 8.5%.

What is Innovex International, Inc.'s EBITDA?

Innovex International, Inc. (INVX) had EBITDA of $193.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Innovex International, Inc. have?

As of fiscal year 2025, Innovex International, Inc. (INVX) had $203.4M in cash and equivalents against $18.9M in long-term debt.

What is Innovex International, Inc.'s gross margin?

Innovex International, Inc. (INVX) had a gross margin of 31.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Innovex International, Inc.'s operating margin?

Innovex International, Inc. (INVX) had an operating margin of 13.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Innovex International, Inc.'s net profit margin?

Innovex International, Inc. (INVX) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Innovex International, Inc.'s return on equity (ROE)?

Innovex International, Inc. (INVX) has a return on equity of 7.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Innovex International, Inc.'s operating cash flow?

Innovex International, Inc. (INVX) generated $190.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Innovex International, Inc.'s total assets?

Innovex International, Inc. (INVX) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Innovex International, Inc. spend on research and development?

Innovex International, Inc. (INVX) invested $6.7M in research and development during fiscal year 2025.

Does Innovex International, Inc. buy back shares?

Yes, Innovex International, Inc. (INVX) spent $9.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Innovex International, Inc. have outstanding?

Innovex International, Inc. (INVX) had 69M shares outstanding as of fiscal year 2025.

What is Innovex International, Inc.'s current ratio?

Innovex International, Inc. (INVX) had a current ratio of 4.91 as of fiscal year 2025, which is generally considered healthy.

What is Innovex International, Inc.'s debt-to-equity ratio?

Innovex International, Inc. (INVX) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Innovex International, Inc.'s return on assets (ROA)?

Innovex International, Inc. (INVX) had a return on assets of 6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Innovex International, Inc.'s P/E ratio?

Innovex International, Inc. (INVX) trades at 32.6x earnings, its market capitalization divided by net income of $61.6M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Innovex International, Inc.'s price-to-sales ratio?

Innovex International, Inc. (INVX) trades at 2.0x sales, its market capitalization divided by revenue of $997.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Innovex International, Inc.'s Altman Z-Score?

Innovex International, Inc. (INVX) has an Altman Z-Score of 7.70, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Innovex International, Inc.'s Piotroski F-Score?

Innovex International, Inc. (INVX) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Innovex International, Inc.'s earnings high quality?

Innovex International, Inc. (INVX) has an earnings quality ratio of 2.29x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Innovex International, Inc. cover its interest payments?

Innovex International, Inc. (INVX) has an interest coverage ratio of 51.37x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Innovex International, Inc.?

Innovex International, Inc. (INVX) scores 73 out of 100 on our Financial Health Score, indicating strong standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.